Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-23

Clinical Trial Update: Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing incobotulinum toxin to a corticosteroid for plantar fasciitis is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroid (corticosteroid)
  • Incobotulinum toxin (incobotulinumtoxinA)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Plantar Fasciitis of Both Feet, Pain | Phase 1 | Status: ACTIVE_NOT_RECRUITING